Correlation Between Summit Therapeutics and Lava Medtech

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Lava Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Lava Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and Lava Medtech Acquisition, you can compare the effects of market volatilities on Summit Therapeutics and Lava Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Lava Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Lava Medtech.

Diversification Opportunities for Summit Therapeutics and Lava Medtech

0.0

Correlation Coefficient

Summit Therapeutics  Lava Medtech

Pay attention - limited upside

The 3 months correlation between Summit and Lava is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Lava Medtech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lava Medtech Acquisition and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Lava Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lava Medtech Acquisition has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Lava Medtech go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Lava Medtech

If you would invest  1,840  in Summit Therapeutics PLC on December 19, 2024 and sell it today you would earn a total of  143.00  from holding Summit Therapeutics PLC or generate 7.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  Lava Medtech Acquisition

Summit Therapeutics PLC

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady primary indicators, Summit Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Lava Medtech Acquisition

Risk-Adjusted Performance

Very Weak

Over the last 90 days Lava Medtech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Lava Medtech is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Summit Therapeutics and Lava Medtech

The main advantage of trading using opposite Summit Therapeutics and Lava Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Lava Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lava Medtech will offset losses from the drop in Lava Medtech's long position.

The idea behind Summit Therapeutics PLC and Lava Medtech Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.